ACCELERON PHARMA INC. Available-for-sale Securities, Amortized Cost Basis
ACCELERON PHARMA INC. had Available-for-sale Securities, Amortized Cost Basis of $284.93 million as of 2018-03-31, per its 10-Q filed 2018-05-08.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecuritiesAmortizedCost · last filed 2018-05-08
- 2018-03-31: Available-for-sale Securities, Amortized Cost Basis $284.93M.
- 2017-12-31: Available-for-sale Securities, Amortized Cost Basis $273.69M.
- 2017-09-30: Available-for-sale Securities, Amortized Cost Basis $127.89M.
- 2017-06-30: Available-for-sale Securities, Amortized Cost Basis $163.66M.
| Period end | Available-for-sale Securities, Amortized Cost Basis |
|---|---|
| 2018-03-31 | $284.93M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $273.69M 10-Q · filed 2018-05-08 |
| 2017-09-30 | $127.89M 10-Q · filed 2017-11-07 |
| 2017-06-30 | $163.66M 10-Q · filed 2017-08-03 |
| 2017-03-31 | $180.46M 10-Q · filed 2017-05-08 |
| 2016-12-31 | $213.86M 10-K · filed 2018-02-27 |
| 2016-09-30 | $220.07M 10-Q · filed 2016-11-03 |
| 2016-06-30 | $225.47M 10-Q · filed 2016-08-04 |
| 2016-03-31 | $214.95M 10-Q · filed 2016-05-05 |
| 2015-12-31 | $108.42M 10-K · filed 2017-03-01 |
| 2015-09-30 | $104.73M 10-Q · filed 2015-11-04 |
| 2015-06-30 | $118.50M 10-Q · filed 2015-08-06 |
| 2015-03-31 | $125.26M 10-Q · filed 2015-05-07 |
| 2014-12-31 | $0.00 10-Q · filed 2015-11-04 |